Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Aug 21, 2014

30339_dirs_2014-08-21_dcde0397-d32d-49de-9e6c-eb556b7ac5f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-08-20

Reporting Person: GAILEY JOHN R (Sr. VP, Gen. Counsel & Sec.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-20 Common Stock M 20000.0000 $22.4850 Acquired 87856.0216 Direct
2014-08-20 Common Stock S 20000.0000 $43.9597 Disposed 67856.0216 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-20 Stock Option (Right to Buy) $22.4850 M 20000.0000 Disposed 2018-02-27 Common Stock (20000.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1455.7472 Indirect
Common Stock 11170.7773 Indirect